Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 59 Records) |
Query Trace: Lymphoma and ROS1[original query] |
---|
Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas. Acta cytologica 2020 8 65 (1): 67-74. Nambirajan Aruna, Dutta Rimlee, Malik Prabhat Singh, Bubendorf Lukas, Jain Deepa |
[Different Gene Mutation Spectrum of the Paired CSF and Plasma Samples in Lung Adenocarcinoma with Leptomeningeal Metastases: the Liquid Biopsy Based on Circulating Tumor DNA]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 8 23 (8): 646-654. Li Huiying, Xie Yu, Lin Yongjuan, Yu Tingting, Yin Zhen |
Quantitative volumetric assessment of the solid portion percentage on CT images to predict ROS1/ALK rearrangements in lung adenocarcinomas. Oncology letters 2020 8 20 (3): 2987-2996. Zheng Jing, Zhou Jianya, Liu Jinpeng, Xu Jingfeng, Sun Ke, Wang Bo, Cao He, Ding Wei, Zhou Jianyi |
[Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 4 23 (5): 337-342. Hu Ying, Yang Xinjie, Nie Lihui, Zhao Dan, An Jun, Li Baol |
ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital. Diagnostic cytopathology 2020 Mar . Cao Ziyang, Wu Wei, Zhang Wei, Li Zhixin, Gao Caixia, Huang Yan, Zhang Lipi |
Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma. Medicine 2020 Jan 99 (3): e18726. Bylicki Olivier, Guisier Florian, Monnet Isabelle, Doubre Hélène, Gervais Radj, Janicot Henri, Perol Maurice, Fournel Pierre, Lamy Régine, Auliac Jean-Bernard, Chouaid Christ |
[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2020 2 43 (2): 120-125. Cao H, Zheng J, Zhao J, Guo X J, Zhou J Y, Ding W, Zhou J |
SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature. Archives of pathology & laboratory medicine 2021 Jan 145 (1): 90-98. Nambirajan Aruna, Singh Varsha, Bhardwaj Nishu, Mittal Saurabh, Kumar Sunil, Jain Deepa |
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers 2020 12 12 (12): . Geraud Arthur, Mezquita Laura, Auclin Edouard, Combarel David, Delahousse Julia, Gougis Paul, Massard Christophe, Jovelet Cécile, Caramella Caroline, Adam Julien, Naltet Charles, Lavaud Pernelle, Gazzah Anas, Lacroix Ludovic, Rouleau Etienne, Vasseur Damien, Mir Olivier, Planchard David, Paci Angelo, Besse Benjam |
Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis. Annals of palliative medicine 2020 Nov 9 (6): 4233-4245. Miao Qian, Zheng Xiaobin, Zhang Longfeng, Jiang Kan, Wu Biao, Lin G |
CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas. Scientific reports 2020 10 10 (1): 16251. Woo Jung Han, Kim Tae Jung, Kim Tae Sung, Han Joung |
Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases. The International journal of biological markers 2020 Oct 1724600820967015. Hu Mingming, Zhang Tongmei, Yang Yuan, Che Nanying, Li Jie, Liu Zichen, Li Baol |
Correlation between combining F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer. European journal of nuclear medicine and molecular imaging 2020 Jan . Ruan Maomei, Liu Liu, Wang Lihua, Lei Bei, Sun Xiaoyan, Chang Cheng, Shen Yan, Xie Wenh |
Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer research and treatment 2021 5 54 (1): 30-39. Choi Yoon Ji, Choi Jung Yoon, Kim Ju Won, Lim Ah Reum, Lee Youngwoo, Chang Won Jin, Lee Soohyeon, Sung Jae Sook, Chung Hee-Joon, Lee Jong Won, Kang Eun Joo, Kim Jung Sun, Lim Taekyu, Kim Hye Sook, Kim Yu Jung, Ahn Mi Sun, Kim Young Saing, Park Ji Hyun, Lim Seungtaek, Cho Sung Shim, Cho Jang Ho, Shin Sang Won, Park Kyong Hwa, Kim Yeul Ho |
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients. Frontiers in oncology 2021 4 11 647598. Yang Jie, Li Hefei, Li Ben, Li Wei, Guo Qiang, Hu Ling, Song Zizheng, Zhou B |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study. Journal of occupational and environmental medicine 2020 Jan Publish Ahead of Print . Yilmaz Senay, Demirci Nilgun Yilmaz, Metintas Selma, Zamani Adil, Karadag Mehmet, Guçlu Ozge A, Kabalak Pinar Akin, Yilmaz Ulku, Ak Guntulu, Kizilgoz Derya, Ozturk Akin, Yilmaz Ufuk, Batum Ozgur, Kavas Murat, Serifoglu Irem, Unsal Meftun, Komurcuoglu Berna E, Cengiz Tuba Inal, Ulubay Gaye, Ozdemirel Tugce S, Ozyurek Berna A, Kavurgaci Suna, Alizoroglu Dursun, Celik Pinar, Erdogan Yurdanur, In Erdal, Aksoy Asude, Altin Sedat, Gunluoglu Gulsah, Metintas Muzaff |
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. Translational oncology 2021 1 14 (1): 100977. Hodkinson Brendan P, Schaffer Michael, Brody Joshua D, Jurczak Wojciech, Carpio Cecilia, Ben-Yehuda Dina, Avivi Irit, Forslund Ann, Özcan Muhit, Alvarez John, Ceulemans Rob, Fourneau Nele, Younes Anas, Balasubramanian Srir |
Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions. Frontiers in oncology 2022 7 12 813158. Dai Yinghuan, Liu Ping, He Wenlong, Yang Lizhen, Ni Yang, Ma Xuejiao, Du Furong, Song Chao, Liu Yang, Sun |
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial. Lung cancer (Amsterdam, Netherlands) 2022 Jul 169 67-76. Soo Ross A, Huat Tan Eng, Hayashi Hidetoshi, Seto Takashi, Lin Chia-Chi, Ou Sai-Hong Ignatius, Kim Dong-Wan, Liu Geoffrey, Abbattista Antonello, Martini Jean-François, Hooi Wong Chew, Toffalorio Francesca, Solomon Benjamin |
The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt. Journal of the Egyptian National Cancer Institute 2022 6 34 (1): 23. Bahnassy Abeer A, Ismail Hoda, Mohanad Marwa, El-Bastawisy Ahmed, Yousef Hend |
Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis. Diagnostics (Basel, Switzerland) 2022 Apr 12 (5): . Pyo Jung-Soo, Kim Nae |
Screening of significant oncogenic changes in air pollution-related lung cancer in Chinese population. Translational cancer research 2022 2 9 (7): 4341-4353. Kanwal Madiha, Ding Xiaojie, Lin Weiming, Cao |
Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. The clinical respiratory journal 2022 Jan . Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi |
Comparing Fractionated and Single-Fraction Gamma Knife Radiosurgery for Brain Metastases From Non-Small-Cell Lung Cancer With a Focus on Driver Alterations. Cureus 2023 8 15 (7): e41849. Mariko Kawashima, Atsuya Akabane, Ryuichi Noda, Masafumi Segawa, Sho Tsunoda, Tomohiro Ino |
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: